{"abstract": "Pfizer\u2019s aggressive strategy may offer lessons for drug makers facing similar losses of patent protection for other blockbuster drugs over the next few years.", "web_url": "https://www.nytimes.com/2011/11/30/health/generic-lipitor-sets-off-an-aggressive-push-by-pfizer.html", "snippet": "Pfizer\u2019s aggressive strategy may offer lessons for drug makers facing similar losses of patent protection for other blockbuster drugs over the next few years.", "lead_paragraph": "For the last year, Pfizer has been laying the groundwork to combat the looming competition against Lipitor, forging deals with insurers, pharmacy benefit managers and patients to meet or beat the price of its generic replacements. ", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2011/11/30/business/LIPITOR/LIPITOR-jumbo.jpg", "height": 622, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2011/11/30/business/LIPITOR/LIPITOR-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2011/11/30/business/LIPITOR/LIPITOR-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "Facing Generic Lipitor Rivals, Pfizer Battles to Protect Its Cash Cow", "kicker": null, "content_kicker": null, "print_headline": "Facing Generic Lipitor Rivals, Pfizer Battles to Protect Its Cash Cow", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Watson Pharmaceuticals Inc", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Ranbaxy Laboratories", "rank": 2, "major": "N"}, {"name": "subject", "value": "Lipitor (Drug)", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 6, "major": "N"}], "pub_date": "2011-11-30T01:55:05+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Duff Wilson", "person": [{"firstname": "Duff", "middlename": null, "lastname": "Wilson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f301b1ea-1b6c-532e-abe2-7ceade53cf76", "word_count": 1288, "uri": "nyt://article/f301b1ea-1b6c-532e-abe2-7ceade53cf76"}